Similarly, Yin et al. reported that EMT was responsible for OXA resistance in CRC through the TGF-β/Smad2/3 pathway, which was associated with a decreased apoptotic rate in resistant cells. This evidence concerns the gene SMAD2 and colorectal carcinoma.